-
Publication Venue For
-
Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort..
127:4091-4102.
2021
-
The impact of the social construct of race on outcomes among bacille Calmette-Guérin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting..
127:3998-4005.
2021
-
Do you mind if I record?: Perceptions and practice regarding patient requests to record clinic visits in oncology.
2021
-
Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trials..
127:3664-3670.
2021
-
The importance of the person/patient/survivor's lived experience across the cancer control continuum.
2021
-
Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.
2021
-
Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study..
127:3214-3222.
2021
-
Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial.
2021
-
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer..
127:2954-2965.
2021
-
Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy..
127:2980-2989.
2021
-
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities..
127:2934-2942.
2021
-
Posttraumatic stress disorder symptoms in patients with acute myeloid leukemia..
127:2500-2506.
2021
-
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)..
127:2204-2212.
2021
-
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)..
127:2251-2261.
2021
-
Systematic review of financial burden assessment in cancer: Evaluation of measures and utility among adolescents and young adults and caregivers..
127:1739-1748.
2021
-
Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure..
127:1483-1494.
2021
-
Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis..
127:757-768.
2021
-
The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma..
127:544-553.
2021
-
Reconciling outcomes for Black men with prostate cancer within and outside the Veterans Health Administration..
127:342-344.
2021
-
Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group..
127:275-283.
2021
-
Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort..
127:310-318.
2021
-
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study..
126:5239-5246.
2020
-
Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)..
126:5311-5318.
2020
-
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer..
126:4485-4497.
2020
-
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis..
126:4332-4340.
2020
-
A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer..
126:3464-3470.
2020
-
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma..
126:3493-3503.
2020
-
Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians..
126:3534-3541.
2020
-
Longitudinal pain and pain interference in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
126:2915-2923.
2020
-
Mind the gap: Gendered publication trends in oncology..
126:2859-2865.
2020
-
Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data..
126:2935-2937.
2020
-
An evolutionary framework for treating pediatric sarcomas..
126:2577-2587.
2020
-
Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes..
126:2679-2686.
2020
-
The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors..
126:2566-2570.
2020
-
The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms..
126:2553-2560.
2020
-
The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma..
126:2547-2552.
2020
-
The Chicago Consensus on peritoneal surface malignancies: Standards..
126:2516-2524.
2020
-
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia..
126:1700-1707.
2020
-
Current multidisciplinary management of brain metastases..
126:1390-1406.
2020
-
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors..
126:1208-1216.
2020
-
Patient-hematologist discordance in perceived chance of cure in hematologic malignancies: A multicenter study..
126:1306-1314.
2020
-
Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers..
126:1077-1089.
2020
-
Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study..
126:1051-1059.
2020
-
Barriers and facilitators of risk-based health care for adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
126:619-627.
2020
-
The impact of the Patient Protection and Affordable Care Act on insurance coverage and cancer-directed treatment in HIV-infected patients with cancer in the United States..
126:559-566.
2020
-
Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016.
126:5293-5302.
2020
-
Findings from the National Navigation Roundtable: A call for competency-based patient navigation training..
125:4350-4359.
2019
-
Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer..
125:4399-4406.
2019
-
Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study..
125:4442-4451.
2019
-
Association of neurologic deficits with surgical outcomes and health-related quality of life after treatment for metastatic epidural spinal cord compression..
125:4224-4231.
2019
-
Effects of cancer history on functional age and mortality..
125:4303-4309.
2019
-
Proton-beam therapy after radical prostatectomy: Continued DVH idolatry?.
125:4136-4138.
2019
-
The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence..
125:3960-3965.
2019
-
Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
125:3873-3881.
2019
-
Glioma incidence and survival variations by county-level socioeconomic measures..
125:3390-3400.
2019
-
Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)..
125:3378-3389.
2019
-
Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma..
125:3457-3466.
2019
-
Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group..
125:3242-3248.
2019
-
Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
125:3059-3067.
2019
-
Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy..
125:3025-3032.
2019
-
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice..
125:2945-2954.
2019
-
The effect of treatment on patient-reported distress after breast cancer diagnosis..
125:3040-3049.
2019
-
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors..
125:2837-2845.
2019
-
Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base..
125:2782-2793.
2019
-
Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review..
125:2115-2122.
2019
-
Breast cancer deaths averted over 3 decades..
125:1482-1488.
2019
-
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer..
125:1459-1469.
2019
-
A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma..
125:1124-1132.
2019
-
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma..
125:1113-1123.
2019
-
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients..
125:382-390.
2019
-
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials..
125:18-44.
2019
-
Place of death for patients with cancer in the United States, 1999 through 2015: Racial, age, and geographic disparities..
124:4408-4419.
2018
-
Suicide risk among cancer survivors: Head and neck versus other cancers..
124:4072-4079.
2018
-
Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma..
124:3819-3829.
2018
-
Genetic determinants of childhood and adult height associated with osteosarcoma risk..
124:3742-3752.
2018
-
The role of external beam radiotherapy in the treatment of hepatocellular cancer..
124:3476-3489.
2018
-
A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors..
124:3427-3435.
2018
-
Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancer..
124:3249-3256.
2018
-
Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study..
124:3220-3230.
2018
-
Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials..
124:3409-3416.
2018
-
Symptom and function profiles of men with localized prostate cancer..
124:2832-2840.
2018
-
Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial..
124:2552-2560.
2018
-
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA..
124:2115-2124.
2018
-
Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis..
124:482-490.
2018
-
Survival of human papillomavirus-associated cancers: Filling in the gaps..
124:18-20.
2018
-
Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer..
123:4886-4894.
2017
-
Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort..
123:4193-4198.
2017
-
Understanding the relationship between the Centers for Medicare and Medicaid Services' Hospital Compare star rating, surgical case volume, and short-term outcomes after major cancer surgery..
123:4259-4267.
2017
-
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system..
123:4122-4129.
2017
-
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients..
123:4004-4012.
2017
-
Reply to Second malignancies in Ewing sarcoma survivors..
123:4075-4076.
2017
-
Exploiting DNA damage without repair: The activity of platinum chemotherapy in BRCA-mutated prostate cancers..
123:3441-3444.
2017
-
Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study..
123:2551-2560.
2017
-
Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials..
123:2472-2481.
2017
-
Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel..
123:2303-2311.
2017
-
What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability..
123:1848-1859.
2017
-
Total neoadjuvant therapy for rectal cancer: An emerging option..
123:1497-1506.
2017
-
Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States..
123:1434-1441.
2017
-
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting..
123:1259-1271.
2017
-
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study..
123:1144-1155.
2017
-
Immunotherapy approaches in the treatment of malignant brain tumors..
123:734-750.
2017
-
Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases..
123:568-575.
2017
-
Impact of chronic disease on emotional distress in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
123:521-528.
2017
-
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial..
123:485-493.
2017
-
Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening..
123:312-318.
2017
-
Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy..
122:3865-3872.
2016
-
Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
122:3687-3696.
2016
-
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)..
122:3555-3563.
2016
-
The efficacy of anti-PD-1 agents in acral and mucosal melanoma..
122:3354-3362.
2016
-
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma..
122:2680-2688.
2016
-
Patterns and predictors of clustered risky health behaviors among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..
122:2747-2756.
2016
-
Improving the quality of survivorship for older adults with cancer..
122:2459-2568.
2016
-
Childhood cancer survivorship research in minority populations: A position paper from the Childhood Cancer Survivor Study..
122:2426-2439.
2016
-
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)..
122:2242-2250.
2016
-
Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer..
122:2091-2100.
2016
-
Is it my cancer or am i just getting older?: Impact of cancer on age-related health conditions of older cancer survivors..
122:1946-1953.
2016
-
Irradiation and immunotherapy: From concept to the clinic..
122:1659-1671.
2016
-
Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study..
122:773-781.
2016
-
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone..
122:758-765.
2016
-
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas..
122:582-587.
2016
-
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies..
122:249-257.
2016
-
Concept-elicitation phase for the development of the pediatric patient-reported outcome version of the Common Terminology Criteria for Adverse Events..
122:141-148.
2016
-
Nonoperative management of rectal cancer..
122:34-41.
2016
-
Group trajectory analysis helps to identify older cancer survivors who benefit from distance-based lifestyle interventions..
121:4433-4440.
2015
-
Specialty care for adult survivors of childhood cancer..
121:4279-4281.
2015
-
Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program..
121:4016-4024.
2015
-
Impact of patient navigation in eliminating economic disparities in cancer care..
121:4025-4034.
2015
-
Longitudinal smoking patterns in survivors of childhood cancer: An update from the Childhood Cancer Survivor Study..
121:4035-4043.
2015
-
Reflections from a chair: Leadership of a clinical department at an academic medical center..
121:3795-3798.
2015
-
Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer..
121:3455-3464.
2015
-
Health care utilization and end-of-life care for older patients with acute myeloid leukemia..
121:2840-2848.
2015
-
Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer..
121:2578-2585.
2015
-
Seduced by technology?.
121:2300-2302.
2015
-
Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis..
121:2164-2174.
2015
-
Patient characteristics associated with the level of patient-reported care coordination among male patients with colorectal cancer in the Veterans Affairs health care system..
121:2207-2213.
2015
-
Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: a report from the Childhood Cancer Survivor Study..
121:1856-1863.
2015
-
Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?.
121:1906.
2015
-
Reply to progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?.
121:1906-1907.
2015
-
Teenage acne and cancer risk in US women: A prospective cohort study..
121:1681-1687.
2015
-
Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib..
121:1405-1413.
2015
-
The effects of cancer and racial disparities in health-related quality of life among older Americans: a case-control, population-based study..
121:1312-1320.
2015
-
Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)..
121:1025-1031.
2015
-
Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013)..
121:978-996.
2015
-
Impact of colorectal cancer diagnosis and treatment on health-related quality of life among older Americans: a population-based, case-control study..
121:943-950.
2015
-
Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors..
121:790-799.
2015
-
Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis..
121:598-604.
2015
-
Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010..
121:102-112.
2015
-
Hereditary link: scientists seek clues in genetic risks for prostate cancer..
120:3847-3848.
2014
-
Patient preferences in advanced or recurrent ovarian cancer..
120:3651-3659.
2014
-
Oncolytic polio virotherapy of cancer..
120:3277-3286.
2014
-
The effect of the setting of a positive surgical margin in soft tissue sarcoma..
120:2866-2875.
2014
-
Daughters and Mothers Against Breast Cancer (DAMES): main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters..
120:2522-2534.
2014
-
Patterns of recurrence after trimodality therapy for esophageal cancer..
120:2099-2105.
2014
-
Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer..
120:1939-1947.
2014
-
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program..
120:1818-1829.
2014
-
Quality of life changes during the pre- to postdiagnosis period and treatment-related recovery time in older women with breast cancer..
120:1881-1889.
2014
-
The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer..
120:1656-1662.
2014
-
Causes of death in long-term survivors of head and neck cancer..
120:1507-1513.
2014
-
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808..
120:1010-1017.
2014
-
Stereotactic body radiotherapy: a critical review for nonradiation oncologists..
120:942-954.
2014
-
Survivorship care plans: is there buy-in from community oncology providers?.
120:722-730.
2014
-
Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program..
120:570-578.
2014
-
Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma..
120:537-547.
2014
-
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites..
120:302-311.
2014
-
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma..
120:52-60.
2014
-
A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy..
119:4205-4211.
2013
-
Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010..
119:4196-4204.
2013
-
A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701..
119:3797-3804.
2013
-
Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer..
119:3653-3661.
2013
-
Pharmacogenetic testing in the face of unclear clinical efficacy: lessons from cytochrome P450 2D6 for tamoxifen..
119:3703-3709.
2013
-
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)..
119:3636-3643.
2013
-
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma..
119:3334-3342.
2013
-
Reply to survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status..
119:3254-3255.
2013
-
Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers..
119:2593-2601.
2013
-
Heart rate decrease during crizotinib treatment and potential correlation to clinical response..
119:1969-1975.
2013
-
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017..
119:1776-1783.
2013
-
A Web-based communication aid for patients with cancer: the CONNECT Study..
119:1437-1445.
2013
-
Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer..
119:1420-1427.
2013
-
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer..
119:1344-1348.
2013
-
Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status..
119:1402-1411.
2013
-
Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trial..
119:1186-1194.
2013
-
Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study..
119:854-862.
2013
-
A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion..
118:6136-6143.
2012
-
Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model..
118:6298-6299.
2012
-
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators..
118:5749-5756.
2012
-
Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study..
118:5679-5687.
2012
-
Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone..
118:5709-5718.
2012
-
Primary care providers' perspectives on discontinuing prostate cancer screening..
118:5518-5524.
2012
-
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging..
118:5320-5330.
2012
-
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer..
118:5414-5423.
2012
-
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1..
118:5171-5178.
2012
-
Neighborhood-level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States..
118:5117-5123.
2012
-
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma..
118:4759-4767.
2012
-
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases..
118:4737-4747.
2012
-
Dental x-rays and risk of meningioma..
118:4530-4537.
2012
-
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis..
118:4309-4320.
2012
-
Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007..
118:4220-4227.
2012
-
Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782..
118:4139-4147.
2012
-
Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer..
118:4339-4345.
2012
-
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation..
118:3801-3811.
2012
-
Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era..
118:3571-3578.
2012
-
Predicting toxicity from radiation therapy--it's genetic, right?.
118:3450-3454.
2012
-
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer..
118:3283-3293.
2012
-
Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival..
118:3260-3267.
2012
-
Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score..
118:3377-3386.
2012
-
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome..
118:3182-3190.
2012
-
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease..
118:2962-2970.
2012
-
Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma..
118:2700-2707.
2012
-
A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma..
118:2069-2077.
2012
-
Modifying effect of MDM4 variants on risk of HPV16-associated squamous cell carcinoma of oropharynx..
118:1684-1692.
2012
-
Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches..
118:1474-1485.
2012
-
Bevacizumab and daily temozolomide for recurrent glioblastoma..
118:1302-1312.
2012
-
Family history of cancer and risk of sporadic differentiated thyroid carcinoma..
118:1228-1235.
2012
-
Medullary thyroid microcarcinoma: a population-level analysis of 310 patients..
118:620-627.
2012
-
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer..
118:386-391.
2012
-
Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy..
118:528-535.
2012
-
Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck..
118:485-492.
2012
-
Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303)..
118:571-578.
2012
-
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study..
118:63-71.
2012
-
Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation..
118:268-277.
2012
-
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809..
117:5579-5588.
2011
-
Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008..
117:5612-5620.
2011
-
Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy..
117:5351-5358.
2011
-
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation..
117:4671-4678.
2011
-
Age-related disparities in the use of radiotherapy for treatment of localized soft tissue sarcoma..
117:4033-4040.
2011
-
Salvage radiation in men after prostate-specific antigen failure and the risk of death..
117:3925-3932.
2011
-
The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy..
117:3963-3971.
2011
-
Having health insurance does not eliminate race/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia..
117:3824-3832.
2011
-
Survivorship navigation outcome measures: a report from the ACS patient navigation working group on survivorship navigation..
117:3575-3584.
2011
-
Occupational outcomes of adult childhood cancer survivors: A report from the childhood cancer survivor study..
117:3033-3044.
2011
-
A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003..
117:2620-2628.
2011
-
Studying cancer in minorities: a look at the numbers..
117:2762-2769.
2011
-
V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials..
117:2478-2488.
2011
-
Re: Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer..
112:2518-2519.
2008
-
Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
2021
-
What do transplant physicians think about palliative care? A national survey study.
2018
-
Preoperative experience for public hospital patients with gynecologic cancer: Do structural barriers widen the gap?
2016
-
The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343.
2015
-
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).
2013
-
Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer.
2013